IMRAN MIR A 4
4 · Rani Therapeutics Holdings, Inc. · Filed Oct 27, 2025
Insider Transaction Report
Form 4
IMRAN MIR A
Director
Transactions
- Purchase
Class A Common Stock
2025-10-23$0.60/sh+2,083,334$1,260,417→ 2,083,334 total - Purchase
Warrant to Purchase Class A Common Stock
2025-10-23+2,083,334→ 2,083,334 totalExercise: $0.48→ Class A Common Stock (2,083,334 underlying)
Holdings
- 74,139(indirect: See footnote)
Class A Common Stock
- 22,660,053(indirect: See Footnote)
Class B Common Stock
Footnotes (4)
- [F1]The Reporting Person purchased these shares in a PIPE offering conducted by the Issuer.
- [F2]The Reporting Person is a General Partner of InCube Ventures II, L.P. and Rani Investment Corp. InCube Labs, L.L.C. is wholly-owned by the Reporting Person and his family. Represents 52,781 shares of Class A Common Stock of the Issuer held by InCube Ventures II, L.P., 13,664 shares of Class A Common Stock of the Issuer held by InCube Labs, L.L.C., and 7,694 Class A Shares held by Rani Investment Corp. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
- [F3]The Reporting Person is a General Partner of InCube Ventures II, L.P., and InCube Labs, LLC is wholly-owned by the Reporting Person and his family. Represents 22,411,124 Class B Shares held by InCube Labs, LLC and 248,929 Class B Shares held by InCube Ventures II, L.P. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
- [F4]The warrants shall be exercisable upon stockholder approval and have a term of exercise equal to five years from the date of such stockholder approval.